FDA Approved Products
6,646 products with lifecycle intelligence, competitive pressure scores, and patent timelines.
GASTROGRAFIN
diatrizoate meglumine and diatrizoate sodium
LOE Approaching
Bracco
ORAL, RECTAL · SOLUTION
1958
NDA30/100
GASTROMARK
ferumoxsil
LOE Approaching
ORAL · SUSPENSION
1996
NDA30/100
GAVISCON
aluminum hydroxide; magnesium trisilicate
LOE Approaching
Sanofi
ORAL · TABLET, CHEWABLE
1983
NDA30/100
GAVRETO
pralsetinib
Peak
Blueprint Medicines
ORAL · CAPSULE
2020
SMNDA30/100
GELNIQUE 3%
oxybutynin
Peak
AbbVie
TRANSDERMAL · GEL, METERED
2011
NDA30/100
GEMCITABINE HYDROCHLORIDE
gemcitabine
Peak
Accord Biopharma
INTRAVENOUS · SOLUTION
breast cancerlung cancer
2017
NDA30/100
GEMCITABINE HYDROCHLORIDE
gemcitabine
Peak
Pfizer
INJECTION · INJECTABLE
breast cancerlung cancer
2011
NDA30/100
GEMZAR
gemcitabine hydrochloride
LOE Approaching
Eli Lilly and Company
INJECTION · INJECTABLE
1996
NDA30/100
GENESA
arbutamine hydrochloride
LOE Approaching
AutoMedicus
INJECTION · INJECTABLE
1997
NDA30/100
GEOCILLIN
carbenicillin indanyl sodium
LOE Approaching
Pfizer
ORAL · TABLET
1972
NDA30/100
GEODON
ziprasidone hydrochloride
LOE Approaching
Pfizer
ORAL · SUSPENSION
2006
NDA30/100
GEODON
ziprasidone mesylate
LOE Approaching
Viatris (2)
INTRAMUSCULAR · POWDER
acute agitation in schizophrenic adult patients for whom treatment with ziprasidone is appropriateschizophrenia in adults+1
2002
NDA30/100
GEODON
ziprasidone
LOE Approaching
Viatris (2)
ORAL · CAPSULE
acute agitation in schizophrenic adult patients for whom treatment with ziprasidone is appropriateschizophrenia in adults+1
2001
NDA30/100
GEREF
sermorelin acetate
LOE Approaching
INJECTION · INJECTABLE
1997
NDA30/100
GEREF
sermorelin acetate
LOE Approaching
INJECTION · INJECTABLE
1990
NDA30/100
GERMA-MEDICA
hexachlorophene
LOE Approaching
TOPICAL · SOLUTION
1978
NDA30/100
GERMA-MEDICA "MG"
hexachlorophene
LOE Approaching
TOPICAL · SOLUTION
1978
NDA30/100
GLEEVEC
imatinib mesylate
LOE Approaching
Novartis
ORAL · TABLET
2003
NDA30/100
GLEEVEC
imatinib mesylate
LOE Approaching
Novartis
ORAL · CAPSULE
2001
NDA30/100
GLEOLAN
aminolevulinic acid hydrochloride
Peak
ORAL · FOR SOLUTION
glioma (suspected World Health Organization Grades IIIIV on preoperative imaging)
2017
NDA30/100
GLEOSTINE
lomustine
LOE Approaching
R-Pharm US
ORAL · CAPSULE
1976
NDA30/100
GLIADEL
carmustine
LOE Approaching
R-Pharm US
INTRACRANIAL · IMPLANT
1996
NDA30/100
GLOFIL-125
sodium iothalamate i-125 injection
LOE Approaching
INJECTION · INJECTABLE
1974
NDA30/100
GLUCAGEN
glucagon hydrochloride
LOE Approaching
Novo Nordisk
INTRAMUSCULAR, INTRAVENOUS · POWDER
1998
NDA30/100